Total Payments
$13,829
2024 Payments
$1,758
Companies
58
Transactions
414
Medicare Patients
8,826
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$8,676 (62.7%)
Consulting$3,000 (21.7%)
Education$1,130 (8.2%)
Travel$738.32 (5.3%)
Gifts$284.77 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,676 | 383 | 62.7% |
| Consulting Fee | $3,000 | 1 | 21.7% |
| Education | $1,130 | 27 | 8.2% |
| Travel and Lodging | $738.32 | 2 | 5.3% |
| Gift | $284.77 | 1 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Valeant Pharmaceuticals North America LLC | $4,178 | 14 | $0 (2017) |
| Astellas Pharma US Inc | $1,188 | 31 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $710.86 | 22 | $0 (2024) |
| PFIZER INC. | $680.97 | 66 | $0 (2024) |
| Boston Scientific Corporation | $663.46 | 10 | $0 (2024) |
| ABBVIE INC. | $578.38 | 22 | $0 (2024) |
| Janssen Biotech, Inc. | $525.91 | 28 | $0 (2024) |
| Teleflex LLC | $383.14 | 11 | $0 (2023) |
| Myriad Genetic Laboratories, Inc. | $341.77 | 16 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $315.49 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,758 | 64 | Dendreon Pharmaceuticals LLC ($242.29) |
| 2023 | $1,370 | 48 | Astellas Pharma US Inc ($238.49) |
| 2022 | $1,199 | 56 | Astellas Pharma US Inc ($207.75) |
| 2021 | $987.08 | 34 | Teleflex LLC ($229.25) |
| 2020 | $300.85 | 10 | Coloplast Corp ($171.51) |
| 2019 | $1,120 | 66 | PFIZER INC. ($226.44) |
| 2018 | $1,437 | 63 | AbbVie, Inc. ($214.41) |
| 2017 | $5,656 | 73 | Valeant Pharmaceuticals North America LLC ($4,178) |
All Payment Transactions
414 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Urology | ||||||
| 12/12/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $148.66 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $33.64 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/26/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: UROLOGY | ||||||
| 11/20/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $87.62 | General |
| Category: Immunotherapy | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $27.92 | General |
| Category: UROLOGY | ||||||
| 11/12/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Oncology | ||||||
| 10/15/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Food and Beverage | In-kind items and services | $25.90 | General |
| Category: Oncology | ||||||
| 10/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $32.79 | General |
| Category: UROLOGY | ||||||
| 10/10/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Oncology | ||||||
| 09/19/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/17/2024 | Calyxo, Inc. | CVAC ASPIRATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Urology | ||||||
| 09/16/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $41.86 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/12/2024 | 180 Medical, Inc. | GENTLECATH (Device) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: CONTINENCE CARE | ||||||
| 09/11/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $27.85 | General |
| Category: ONCOLOGY | ||||||
| 09/09/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: UROLOGY | ||||||
| 09/05/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: HORMONE THERAPY | ||||||
| 09/05/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: HORMONE THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 2,293 | 3,470 | $615,636 | $275,653 |
| 2022 | 25 | 2,222 | 3,209 | $585,884 | $263,432 |
| 2021 | 24 | 2,291 | 3,307 | $592,446 | $287,548 |
| 2020 | 25 | 2,020 | 3,110 | $505,296 | $208,087 |
Total Patients
8,826
Total Services
13,096
Medicare Billing
$1.0M
Procedure Codes
101
All Medicare Procedures & Services
101 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 52442 | Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | Office | 2023 | 18 | 94 | $134,890 | $73,277 | 54.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 404 | 669 | $133,800 | $66,424 | 49.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 96 | 109 | $43,055 | $23,362 | 54.3% |
| 52441 | Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | Office | 2023 | 18 | 18 | $33,840 | $20,720 | 61.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 13 | 132 | $82,500 | $17,921 | 21.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 106 | 190 | $25,650 | $13,700 | 53.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 74 | 74 | $25,900 | $9,766 | 37.7% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 18 | 20 | $9,400 | $5,937 | 63.2% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 224 | 301 | $15,050 | $5,340 | 35.5% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 38 | 41 | $8,200 | $5,290 | 64.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 32 | $7,700 | $4,792 | 62.2% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 14 | 14 | $11,340 | $4,560 | 40.2% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 16 | 16 | $6,720 | $3,451 | 51.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 278 | 356 | $17,800 | $3,345 | 18.8% |
| 51725 | Simple measurement of pressure of urine flow in bladder | Office | 2023 | 12 | 13 | $5,200 | $2,595 | 49.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 226 | 304 | $4,560 | $2,521 | 55.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $6,205 | $2,404 | 38.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 41 | 102 | $5,100 | $2,107 | 41.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 26 | 41 | $4,100 | $1,949 | 47.5% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 92 | 100 | $15,000 | $1,155 | 7.7% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 12 | 20 | $2,700 | $1,092 | 40.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 313 | 482 | $7,230 | $1,040 | 14.4% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 16 | 18 | $3,150 | $963.18 | 30.6% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 13 | 33 | $1,650 | $897.96 | 54.4% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 151 | 229 | $3,435 | $702.86 | 20.5% |
About Dr. Stephen King, MD
Dr. Stephen King, MD is a Urology healthcare provider based in Federal Way, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891897468.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen King, MD has received a total of $13,829 in payments from pharmaceutical and medical device companies, with $1,758 received in 2024. These payments were reported across 414 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($8,676).
As a Medicare-enrolled provider, King has provided services to 8,826 Medicare beneficiaries, totaling 13,096 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 101 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Federal Way, WA
- Active Since 09/02/2006
- Last Updated 12/06/2012
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1891897468
Products in Payments
- PROVENGE (Drug) $4,888
- XTANDI (Drug) $437.95
- TOVIAZ (Drug) $330.10
- Nubeqa (Drug) $300.25
- Rezum (Device) $295.28
- SPEEDICATH (Device) $259.04
- XIAFLEX (Biological) $248.12
- ERLEADA (Drug) $245.60
- ORGOVYX (Drug) $238.34
- Lupron (Drug) $229.68
- UroLift System (Device) $229.25
- FIRMAGON (Drug) $204.85
- ZYTIGA (Drug) $203.66
- BOTOX (Biological) $190.32
- AQUABEAM ROBOTIC SYSTEM (Device) $186.47
- JELMYTO (Drug) $178.27
- Erleada (Drug) $175.65
- Myrbetriq (Drug) $175.46
- PROLARIS (Device) $171.83
- YONSA (Drug) $164.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.